News

Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO Impulse System for treatment of STEMI…
Read More...

Enteris BioPharma announced its entry into a definitive licensing agreement with Cara Therapeutics (Nasdaq: CARA) for Enteris' Peptelligence technology in the ongoing development of an…
Read More...

TOKYO & Astellas Pharma Inc. and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application…
Read More...

Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility…
Read More...

Innovent Biologics, Inc. (Innovent) announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for the development and potential commercialization of…
Read More...

Enable Injections, Inc. (Enable), a company developing and manufacturing investigational wearable infusion devices for combination products, announced it has entered into a development…
Read More...

Alligator Bioscience announces that a license agreement has been reached with Biotheus Inc. ("Biotheus"), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the…
Read More...

Emendo Biotherapeutics announced that the company achieved the first milestone as laid out in the agreements with Takeda Pharmaceutical Company Limited (Takeda), resulting in the…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an exclusive agreement to in-license a triple reuptake inhibitor (TRI), TNX-1600 (formerly D-578), to treat posttraumatic stress disorder…
Read More...

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for the VX-445 (elexacaftor), tezacaftor and ivacaftor…
Read More...

Vaxxilon, a privately held company working on synthetic vaccines, has been awarded a grant of up to $1.4 million from CARB-X, with the possibility of $3.1 million more based on the…
Read More...

U.S.-based company Elanco Animal Health has entered into a definitive agreement to acquire Bayer’s Animal Health business, Bayer announced on Tuesday. The transaction is valued at 7.6…
Read More...

AstraZeneca announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpoint with a…
Read More...

The U.S. Food and Drug Administration approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another option for the…
Read More...

iBio, Inc. announced that it has entered into a Master Services Agreement with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation, to produce recombinant human…
Read More...

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to…
Read More...

Nabriva Therapeutics plc announced that the U.S. Food and Drug Administration (FDA) has approved Nabriva’s new drug applications for the oral and intravenous (IV) formulations of…
Read More...

Mateon Therapeutics and PointR Data announced that they have entered into a definitive agreement with respect to a merger, creating a publicly traded artificial intelligence (“AI”)…
Read More...

Sarepta Therapeutics announced it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) seeking…
Read More...